170 related articles for article (PubMed ID: 23013070)
1. What's preventing us from preventing type 2 diabetes?
Fradkin JE; Roberts BT; Rodgers GP
N Engl J Med; 2012 Sep; 367(13):1177-9. PubMed ID: 23013070
[No Abstract] [Full Text] [Related]
2. [Diabetes prevention program (metformin)].
Kusaka I; Nagasaka S
Nihon Rinsho; 2005 Feb; 63 Suppl 2():471-7. PubMed ID: 15779424
[No Abstract] [Full Text] [Related]
3. Incorporating practical lifestyle management for obesity.
Bestermann WH
J Fam Pract; 2010 May; 59(5 Suppl):S3-8. PubMed ID: 20544055
[No Abstract] [Full Text] [Related]
4. [Characteristic of metformin for treatment of impaired glucose tolerance].
Ishida W; Satoh J
Nihon Rinsho; 2005 Feb; 63 Suppl 2():433-7. PubMed ID: 15779418
[No Abstract] [Full Text] [Related]
5. (5) Prevention or delay of type 2 diabetes.
American Diabetes Association
Diabetes Care; 2015 Jan; 38 Suppl():S31-2. PubMed ID: 25537704
[No Abstract] [Full Text] [Related]
6. [Treatment for patients with impaired glucose tolerance].
Tawaramoto K; Kaku K
Nihon Rinsho; 2005 Feb; 63 Suppl 2():423-7. PubMed ID: 15779416
[No Abstract] [Full Text] [Related]
7. Diabetes prevention program: education is vital.
Fain JA
Diabetes Educ; 2002; 28(4):474. PubMed ID: 12224190
[No Abstract] [Full Text] [Related]
8. [Diabetes drugs and body weight].
Eriksson J; Laine M
Duodecim; 2013; 129(1):73-8. PubMed ID: 23431885
[TBL] [Abstract][Full Text] [Related]
9. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
[TBL] [Abstract][Full Text] [Related]
10. [Pathophysiological conditions progressing from impaired glucose tolerance: type 2 diabetes mellitus].
Asakura T; Ito Y
Nihon Rinsho; 2005 Feb; 63 Suppl 2():237-41. PubMed ID: 15779378
[No Abstract] [Full Text] [Related]
11. Reduction of body iron stores and the prevention of type 2 diabetes.
Mascitelli L; Pezzetta F
Am J Med; 2007 Jan; 120(1):e13; author reply e15. PubMed ID: 17208061
[No Abstract] [Full Text] [Related]
12. Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin.
Derosa G; Salvadeo SA; D'Angelo A; Fogari E; Ragonesi PD; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
Arch Med Res; 2008 May; 39(4):412-9. PubMed ID: 18375253
[TBL] [Abstract][Full Text] [Related]
13. Summaries for patients. The cost-effectiveness of strategies to prevent type 2 diabetes.
Ann Intern Med; 2005 Mar; 142(5):I28. PubMed ID: 15738446
[No Abstract] [Full Text] [Related]
14. Metformin as a weight-loss tool in "at-risk" obese adolescents: a magic bullet?
Kasa-Vubu JZ
J Pediatr; 2008 Jun; 152(6):750-2. PubMed ID: 18492507
[No Abstract] [Full Text] [Related]
15. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.
Caro JJ; Getsios D; Caro I; Klittich WS; O'Brien JA
Diabet Med; 2004 Nov; 21(11):1229-36. PubMed ID: 15498090
[TBL] [Abstract][Full Text] [Related]
16. FPIN's clinical inquiries. Metformin therapy and diabetes prevention in adolescents who are obese.
RodrÃguez JE; Shearer B; Slawson DC
Am Fam Physician; 2007 Nov; 76(9):1357-8. PubMed ID: 18019881
[No Abstract] [Full Text] [Related]
17. Intensifying type 2 diabetes therapy: assessing the options. Introduction.
Brunton SA
J Fam Pract; 2011 Sep; 60(9 Suppl):S3. PubMed ID: 21912772
[No Abstract] [Full Text] [Related]
18. [Diet therapy for impaired glucose tolerance].
Ogura M; Seino Y
Nihon Rinsho; 2005 Feb; 63 Suppl 2():503-8. PubMed ID: 15779430
[No Abstract] [Full Text] [Related]
19. Top ways to reduce your risk of developing diabetes.
Mayo Clin Health Lett; 2010 Sep; 28(9):4. PubMed ID: 20925157
[No Abstract] [Full Text] [Related]
20. Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial.
Zinman B; Harris SB; Gerstein HC; Young TK; Raboud JM; Neuman J; Hanley AJ
Diabetes Obes Metab; 2006 Sep; 8(5):531-7. PubMed ID: 16918588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
